Characterization of a novel anti-CD20 StradobodyTM with potent in vitro anti-tumor activity (TUM7P.935)
Xiaoyu Zhang(Agilent Technologies (United States)), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Henrik S. Olsen(Gliknik (United States)), Michelle A. Sallin(University of Maryland, Baltimore), Shaodong Chen(Xiamen University), David S. Block(Gliknik (United States)), Erin Burch(Syngenta (United States))
Cited by 0
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548
618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target
|The Journal of Urology|2005|387